Advancements in Diagnostic Tools for Viral Infections: Traditional Methods to Next-generation Sequencing

Kristina Berggren*

Abstract

Advancements in diagnostic tools for viral infections have significantly improved our ability to detect and characterize viral pathogens, facilitating more accurate diagnosis and timely intervention. This review provides an overview of the transition from traditional methods to Next-Generation Sequencing (NGS) in the field of viral diagnostics. Traditional diagnostic techniques, such as viral culture, antigen detection assays, and Polymerase Chain Reaction (PCR), have long been the cornerstone of viral infection diagnosis but are often limited by sensitivity, specificity, and the ability to detect novel or emerging pathogens. In contrast, NGS offers unparalleled capabilities for comprehensive viral genome analysis, enabling rapid identification of known viruses, discovery of novel pathogens, and characterization of viral diversity within populations. This review discusses the principles, advantages, and challenges associated with both traditional methods and NGS-based approaches, highlighting their respective roles in clinical diagnostics, epidemiological surveillance, and outbreak investigation. Furthermore, it explores the potential impact of NGS technologies on advancing our understanding of viral pathogenesis, evolution, and host-virus interactions, ultimately guiding the development of innovative strategies for viral infection control and prevention.

Keywords

Viral infections • Diagnostic tools • Traditional methods

Introduction

The accurate and timely diagnosis of viral infections is crucial for effective patient management, disease surveillance, and public health interventions. Over the years, diagnostic techniques have evolved significantly, from traditional methods to cutting-edge technologies like Next-Generation Sequencing (NGS). This article explores the spectrum of diagnostic tools available for viral infections, highlighting their strengths, limitations, and the role of NGS in revolutionizing viral detection and characterization. Traditional methods for diagnosing viral infections often rely on techniques such as viral culture, serological assays, and Polymerase Chain Reaction (PCR) based tests. Viral culture involves growing viruses in cell cultures, which can be time-consuming and may lack sensitivity. Serological assays detect antibodies produced by the immune system in response to viral infections, providing evidence of past or current infection. However, these assays may not be suitable for early diagnosis or distinguishing between different viral strains. PCR-based tests detect viral nucleic acids with high specificity and sensitivity, making them a cornerstone of viral diagnostics. However, PCR assays typically target specific viral sequences, limiting their utility for detecting novel or unknown viruses.

Literature Review

Traditional diagnostic methods for viral infections have been instrumental in the field of medicine for decades, providing the foundation upon which modern diagnostic techniques have been built. These methods, though relatively simple compared to the sophisticated technologies available today, have played a critical role in the diagnosis, surveillance, and management of viral diseases. Viral culture involves growing viruses in cell cultures under controlled laboratory conditions. This method allows for the isolation and identification of viral pathogens from clinical specimens such as throat swabs, nasal secretions, or blood samples. Once isolated, viruses can be further characterized using various techniques such as microscopy, serological assays, or molecular methods. Although viral culture is considered the gold standard for confirming viral infections, it is labor-intensive, time-consuming, and may lack sensitivity for certain viruses.

Serological assays detect antibodies produced by the immune system in response to viral infections. These assays, such as Enzyme-Linked Immuno Sorbent Assays (ELISA) and neutralization assays, are used to detect specific antibodies (IgM, IgG) against viral antigens in patient serum or plasma samples. Serological tests are valuable for diagnosing past infections, determining immune status, and conducting seroprevalence studies. However, they may not be suitable for early diagnosis or distinguishing between different viral strains. Direct antigen detection methods detect viral antigens in clinical specimens using techniques such as immunofluorescence assays, enzyme immunoassays, or lateral flow assays. These assays detect viral proteins or components in patient samples, providing rapid diagnosis of acute infections. Direct antigen detection is commonly used for diagnosing respiratory viruses (e.g., influenza, respiratory syncytial virus) and gastrointestinal viruses (e.g., norovirus, rotavirus) in clinical settings.

PCR-based tests detect viral nucleic acids with high specificity and sensitivity, making them one of the most widely used methods for viral diagnostics. PCR amplifies specific regions of viral genomes using primer sequences complementary to the target sequences. Real-time PCR (qPCR) allows for quantitative detection of viral nucleic acids, while reverse transcription PCR (RT-PCR) is used to detect RNA viruses by first converting RNA into complementary DNA (cDNA). PCR-based tests are invaluable for diagnosing a wide range of viral infections, including HIV, hepatitis viruses, herpesviruses, and emerging pathogens like SARS-CoV-2.

Discussion

in clinical specimens. Viral particles are negatively stained and visualized using an electron microscope, allowing for the rapid identification of viruses based on their morphology and size. Although EM is less commonly used today due to its low sensitivity and limited ability to identify specific viruses, it remains a valuable tool for research and surveillance purposes. Traditional diagnostic methods continue to play a vital role in the diagnosis and surveillance of viral infections, especially in resource-limited settings where access to advanced technologies may be limited. While newer diagnostic techniques such as next-generation sequencing offer greater sensitivity and specificity, traditional methods remain relevant for routine clinical practice, outbreak investigations, and public health surveillance.

The integration of both traditional and modern diagnostic approaches is essential for effectively combating viral diseases and ensuring optimal patient care. The advent of molecular diagnostic techniques has revolutionized the field of viral diagnostics. Techniques such as real-time PCR and nucleic acid amplification tests offer rapid and sensitive detection of viral nucleic acids, enabling early diagnosis and monitoring of viral infections. These methods are widely used in clinical laboratories and have greatly improved our ability to detect and characterize viral pathogens. Point-of-care testing has emerged as a valuable tool for rapid diagnosis of viral infections in clinical settings. POC tests are designed to be simple, portable, and easy to use, allowing for rapid detection of viral antigens or nucleic acids at the patient's bedside or in resource-limited settings. These tests are particularly useful for screening large numbers of individuals during outbreaks or in areas with limited access to laboratory facilities. NGS technologies have revolutionized our ability to sequence and analyze the genomes of viruses with unprecedented speed and accuracy.

Unlike traditional methods that target specific viral sequences, NGS allows for unbiased sequencing of all nucleic acids present in a sample, providing a comprehensive view of the viral population. This makes NGS particularly valuable for detecting emerging viral pathogens, monitoring viral evolution, and investigating outbreaks of infectious diseases. Pathogen Discovery: NGS can identify novel or unknown viral pathogens by sequencing all nucleic acids present in a sample, allowing for the detection of viruses that may evade traditional diagnostic methods. Genomic Characterization: NGS enables detailed genomic characterization of viral strains, including analysis of genetic variations, mutations, and viral evolution. This information is crucial for understanding the epidemiology and pathogenesis of viral infections. Outbreak Investigation: During outbreaks of infectious diseases, NGS can rapidly sequence viral genomes from clinical samples, providing insights into the source of the outbreak, transmission dynamics, and potential interventions [1-6].

Antiviral Resistance Testing: NGS can be used to detect antiviral resistance mutations in viral genomes, guiding the selection of appropriate antiviral therapies and monitoring for the emergence of drug-resistant strains. While NGS offers numerous advantages for viral diagnostics, it also presents several challenges, including the need for specialized equipment, bioinformatics expertise, and data analysis capabilities. Additionally, the high cost and complexity of NGS may limit its accessibility in resource-limited settings. Future research efforts are focused on addressing these challenges and optimizing NGS technologies for routine viral diagnostics.

Conclusion

The field of viral diagnostics has witnessed remarkable advancements, from traditional methods to state-of-the-art technologies like NGS. While traditional diagnostic methods remain essential for routine clinical practice, NGS has emerged as a powerful tool for detecting, characterizing, and monitoring viral infections. By combining the strengths of both traditional and next-generation approaches, researchers and clinicians can improve our ability to diagnose and manage viral diseases effectively, ultimately leading to better patient outcomes and enhanced public health surveillance.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Choi, Jane Ru. "Development of point-of-care biosensors for COVID-19." Front Chem 8 (2020): 517.

   Google Scholar, Crossref, Indexed at

2. Yüce, Meral, Elif Filiztekin and Korin Gasia Özkaya. "COVID-19 diagnosis—A review of current methods." Biosens Bioelectron 172 (2021): 112752.

   Google Scholar, Crossref, Indexed at

3. Ejazi, Sarfaraz Ahmad, Sneha Ghosh and Nahid Ali. "Antibody detection assays for COVID‐19 diagnosis: An early overview." Immunol Cell Biol 99 (2021): 21-33.

   Google Scholar, Crossref, Indexed at

4. Mori, Yasuyoshi and Tsugunori Notomi. "Loop-mediated isothermal amplification (LAMP): A rapid, accurate, and cost-effective diagnostic method for infectious diseases." J Infect Chemother 15 (2009): 62-69.

   Google Scholar, Crossref, Indexed at

5. Nagamine, Kentaro, Tesu Hase and T. J. M. C. P. Notomi. "Accelerated reaction by loop-mediated isothermal amplification using loop primers." Mol Cell Probe 16 (2002): 223-229.

   Google Scholar, Crossref, Indexed at

6. Filchakova, Olena, Dina Dossym, Aisha Ilyas and Tamila Kuanysheva, et al. "Review of COVID-19 testing and diagnostic methods." Talanta 244 (2022): 123409.

   Google Scholar, Crossref, Indexed at